Mustang Bio Inc Sustainability Reports
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating cell therapies into potential cures for difficult-to-treat cancers and autoimmune diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493004W0VC1DPECQ779
FIGI: BBG00FXTN439
3 reports from 2022 to 2024
